Peking University hospital of Stomatology
🇨🇳China
Clinical Trials
2
Active:2
Completed:0
Trial Phases
2 Phases
Phase 2:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 2
1 (50.0%)Clinical Evaluation of Polycation-based New Dental Desensitizer on Dentin Hypersensitivity
Not Applicable
Active, not recruiting
- Conditions
- Dentin Sensitivity
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Peking University Hospital of Stomatology
- Target Recruit Count
- 40
- Registration Number
- NCT06378255
- Locations
- 🇨🇳
Peking University School and Hospital of Stomatology, Beijing, Beijing, China
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
Phase 2
Active, not recruiting
- Conditions
- Oral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2023-08-24
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Peking University Hospital of Stomatology
- Target Recruit Count
- 110
- Registration Number
- NCT06009861
- Locations
- 🇨🇳
Peking University School and Hospital Stomatology, Beijing, Beijing, China
🇨🇳Affiliated Hospital of Hebei University, Baoding, Hebei, China
🇨🇳Tangshan People's Hospital, Tangshan, Hebei, China
News
No news found